A molecular targeting against nuclear factor‐<i>κ</i>B, as a chemotherapeutic approach for human malignant mesothelioma

Sho Nishikawa(Hokkaido University), Hiroshi Matsuda(Life Science Institute)
Cancer Medicine
February 10, 2014
Cited by 13


Related Papers